These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 36550158)
21. Investigating Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639 [No Abstract] [Full Text] [Related]
22. ERK1/2 Phosphorylation of FHOD Connects Signaling and Nuclear Positioning Alternations in Cardiac Laminopathy. Antoku S; Wu W; Joseph LC; Morrow JP; Worman HJ; Gundersen GG Dev Cell; 2019 Dec; 51(5):602-616.e12. PubMed ID: 31794718 [TBL] [Abstract][Full Text] [Related]
23. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction. Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344 [TBL] [Abstract][Full Text] [Related]
24. Modulation of cytoskeleton in cardiomyopathy caused by mutations in Chatzifrangkeskou M; Le Dour C; Muchir A Am J Physiol Cell Physiol; 2023 Jun; 324(6):C1223-C1235. PubMed ID: 37125775 [TBL] [Abstract][Full Text] [Related]
25. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166 [TBL] [Abstract][Full Text] [Related]
26. BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C-deficient mice. Auguste G; Rouhi L; Matkovich SJ; Coarfa C; Robertson MJ; Czernuszewicz G; Gurha P; Marian AJ J Clin Invest; 2020 Sep; 130(9):4740-4758. PubMed ID: 32484798 [TBL] [Abstract][Full Text] [Related]
28. The LMNA p.R541C mutation causes dilated cardiomyopathy in human and mice. Yang L; Sun J; Chen Z; Liu L; Sun Y; Lin J; Hu X; Zhao M; Ma Y; Lu D; Li Y; Guo Y; Dong E Int J Cardiol; 2022 Sep; 363():149-158. PubMed ID: 35714719 [TBL] [Abstract][Full Text] [Related]
29. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations. Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354 [TBL] [Abstract][Full Text] [Related]
30. Functional Characterization of a Novel Truncating Mutation in Lamin A/C Gene in a Family with a Severe Cardiomyopathy with Conduction Defects. Gerbino A; Bottillo I; Milano S; Lipari M; Zio R; Morlino S; Mola MG; Procino G; Re F; Zachara E; Grammatico P; Svelto M; Carmosino M Cell Physiol Biochem; 2017; 44(4):1559-1577. PubMed ID: 29197877 [TBL] [Abstract][Full Text] [Related]
31. mTOR Inhibition Prolongs Survival and Has Beneficial Effects on Heart Function After Onset of Lamin A/C Gene Mutation Cardiomyopathy in Mice. Wu W; Jin Q; Östlund C; Tanji K; Shin JY; Han J; Leu CS; Kushner J; Worman HJ Circ Heart Fail; 2024 Apr; 17(4):e011110. PubMed ID: 38567527 [TBL] [Abstract][Full Text] [Related]